Marco Taglietti's Net Worth
$2.19 Million
Who is Marco Taglietti?
Marco Taglietti has an estimated net worth of $2.19 Million. This is based on reported shares across multiple companies, which include DELCATH SYSTEMS, INC., SCYNEXIS INC, Aquestive Therapeutics, Inc., Forest Laboratories, LLC, and NephroGenex, Inc..
SEC CIK
Marco Taglietti's CIK is 0001408870
Past Insider Trading and Trends
2015 was Marco Taglietti's most active year for acquiring shares with 19 total transactions. Marco Taglietti's most active month to acquire stocks was the month of November. 2014 was Marco Taglietti's most active year for disposing of shares, totalling 19 transactions. Marco Taglietti's most active month to dispose stocks was the month of June. 2020 saw Marco Taglietti paying a total of $250,000.00 for 986,000 shares, this is the most they've acquired in one year. In 2013 Marco Taglietti cashed out on 12,835 shares for a total of $703,483.48, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
DELCATH SYSTEMS, INC. (DCTH) Snapshot price: $4.64
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 6K |
—
|
—
| 6K |
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +1,000.00% | 200K |
$0.53 | $106,783.00 | 220K |
Jul 27 - Jul 28
| |||
Form 4
|
∞
| 20K |
—
|
—
| 20K |
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
SCYNEXIS INC (SCYX) Snapshot price: $1.995
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +38.06% | 75K |
$3.00 | $225,000.00 | 272.07K |
Apr 26
| |||
Form 4
| +79.44% | 87.2K |
—
|
—
| 196.97K |
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
| +57.42% | 40K |
$6.25 | $250,000.00 | 109.67K |
Dec 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
| +31.62% | 166.67K |
$0.90 | $150,000.30 | 693.68K |
Dec 12
| |||
Form 4
| +1.94% | 10K |
$1.11 | $11,100.00 | 526.01K |
Aug 20 - Aug 21
| |||
Form 4
| +1.98% | 10.02K |
$1.01 | $10,115.15 | 516.01K |
Aug 15
| |||
Form 4
| +5.20% | 25K |
$1.63 | $40,750.00 | 506K |
Apr 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
| +5.49% | 25K |
$0.69 | $17,250.00 | 480K |
Jan 10
| |||
Form 4
| +5.81% | 25K |
$0.46 | $11,500.00 | 455K |
Dec 31
| |||
Form 4
| +6.19% | 25K |
$1.29 | $32,250.00 | 429K |
Aug 23
| |||
Form 4
| +32.89% | 100K |
$1.69 | $169,000.00 | 404K |
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
| +3.41% | 10K |
$2.23 | $22,300.00 | 303K |
Sep 22
| |||
Form 4
| +1.74% | 5K |
$1.85 | $9,248.32 | 292K |
Aug 22 - Aug 23
| |||
Form 4
| +3.61% | 10K |
$1.61 | $16,100.00 | 287K |
Aug 15
| |||
Form 4
| +9.92% | 25K |
$1.69 | $42,250.00 | 277K |
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
| +11.06% | 25K |
$3.30 | $82,500.00 | 251K |
Dec 21
| |||
Form 4
| +80.00% | 100K |
$2.39 | $239,000.00 | 225K |
Jun 24
| |||
Form 4
| +0.20% | 246 |
$3.20 | $787.20 | 125K |
May 25
| |||
Form 4
| +4.84% | 5.75K |
$3.26 | $18,758.04 | 124.75K |
May 25
| |||
Form 4
| +4.85% | 5.5K |
$3.37 | $18,535.00 | 119K |
May 24
| |||
Form 4
| +7.08% | 7.5K |
$3.14 | $23,580.00 | 113.5K |
May 20 - May 23
| |||
Form 4
| +6.00% | 6K |
$3.07 | $18,420.00 | 106K |
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
| +29.42% | 22.73K |
$6.79 | $154,434.40 | 100K |
Nov 23 - Nov 24
| |||
Form 4
| +47.83% | 25K |
$7.82 | $195,500.00 | 77.27K |
Aug 31
| |||
Form 4
| +4.53% | 2.27K |
$7.08 | $16,059.69 | 52.27K |
Aug 27 - Aug 28
| |||
Form 4
|
∞
| 50K |
$7.07 | $353,300.00 | 50K |
Aug 25 - Aug 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Aquestive Therapeutics, Inc. (AQST) Snapshot price: $2.655
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Forest Laboratories, LLC No price found
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -93.74K |
—
|
—
|
0
|
Jul 1
| |||
Form 4
| -3.12% | -3.02K |
$92.23 | -$278,165.68 | 93.74K |
May 15
| |||
Form 4
| -8.88% | -9.43K |
$56.33 | -$531,182.71 | 96.76K |
Dec 6 - Dec 7
| |||
Form 4
| -2.16% | -2.35K |
$55.87 | -$131,171.02 | 106.19K |
Dec 5
| |||
Form 4
| +17.19% | 15.92K |
—
|
—
| 108.54K |
May 21
| |||
Form 4
| -1.10% | -1.06K |
$38.88 | -$41,129.75 | 94.73K |
May 15
| |||
Form 4
| -7.42% | -7.51K |
$35.78 | -$268,743.58 | 93.67K |
Dec 7 - Dec 8
| |||
Form 4
| -3.89% | -4.09K |
$35.83 | -$146,524.25 | 101.19K |
Dec 6
| |||
Form 4
| -2.13% | -2.29K |
$35.87 | -$82,214.04 | 105.28K |
Dec 5
| |||
Form 4
| -10.78% | -13.00K |
$35.51 | -$461,630.50 | 107.57K |
Sep 6
| |||
Form 4
| +7.68% | 8.6K |
—
|
—
| 120.57K |
May 7
| |||
Form 4
| -3.01% | -3.48K |
$29.87 | -$103,857.99 | 111.97K |
Dec 8
| |||
Form 4
| -3.21% | -3.83K |
$30.13 | -$115,378.75 | 115.44K |
Dec 7
| |||
Form 4
| -3.76% | -4.66K |
$30.08 | -$140,135.93 | 119.28K |
Dec 6
| |||
Form 4
| +18.22% | 19.1K |
—
|
—
| 123.93K |
Dec 5
| |||
Form 4
| -2.78% | -3.00K |
$34.72 | -$104,164.50 | 104.83K |
May 23
| |||
Form 4
| -2.47% | -2.73K |
$32.12 | -$87,591.24 | 107.83K |
Dec 8
| |||
Form 4
| -3.18% | -3.64K |
$32.20 | -$117,061.02 | 110.56K |
Dec 7
| |||
Form 4
| +63.69% | 44.43K |
$32.17 | -$18,301.88 | 114.2K |
Dec 6
| |||
Form 4
| -4.12% | -3.00K |
$32.71 | -$98,139.60 | 69.77K |
Nov 18
| |||
Form 4
| -3.81% | -2.88K |
$30.77 | -$88,740.68 | 72.77K |
Dec 8
| |||
Form 4
| +108.69% | 39.4K |
$31.45 | -$18,898.44 | 75.65K |
Dec 6 - Dec 7
| |||
Form 4
| +480.00% | 30K |
—
|
—
| 36.25K |
Dec 8
| |||
Form 4
|
∞
| 6.25K |
—
|
—
| 6.25K |
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
NephroGenex, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |